These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10837430)

  • 1. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC.
    Caroff N; Espaze E; Gautreau D; Richet H; Reynaud A
    J Antimicrob Chemother; 2000 Jun; 45(6):783-8. PubMed ID: 10837430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AmpC promoter and attenuator mutations affect function of three Escherichia coli strains.
    Yu W; Bing L; Zhenhua L
    Curr Microbiol; 2009 Sep; 59(3):244-7. PubMed ID: 19484300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. -11 Mutation in the ampC promoter increasing resistance to beta-lactams in a clinical Escherichia coli strain.
    Corvec S; Caroff N; Espaze E; Marraillac J; Reynaud A
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3265-7. PubMed ID: 12234856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most Escherichia coli strains overproducing chromosomal AmpC beta-lactamase belong to phylogenetic group A.
    Corvec S; Prodhomme A; Giraudeau C; Dauvergne S; Reynaud A; Caroff N
    J Antimicrob Chemother; 2007 Oct; 60(4):872-6. PubMed ID: 17660264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.
    Caroff N; Espaze E; Bérard I; Richet H; Reynaud A
    FEMS Microbiol Lett; 1999 Apr; 173(2):459-65. PubMed ID: 10227175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.
    Tracz DM; Boyd DA; Hizon R; Bryce E; McGeer A; Ofner-Agostini M; Simor AE; Paton S; Mulvey MR;
    FEMS Microbiol Lett; 2007 May; 270(2):265-71. PubMed ID: 17326753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two RT-PCR methods for quantifying ampC specific transcripts in Escherichia coli strains.
    Corvec S; Caroff N; Espaze E; Marraillac J; Drugeon H; Reynaud A
    FEMS Microbiol Lett; 2003 Nov; 228(2):187-91. PubMed ID: 14638423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
    Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
    J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and molecular characterization of AmpC-producing clinical isolates of Escherichia coli from southeastern Iran.
    Shayan S; Bokaeian M; Shahraki S
    Microb Drug Resist; 2014 Apr; 20(2):104-7. PubMed ID: 24224496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.
    Siu LK; Lu PL; Chen JY; Lin FM; Chang SC
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2138-44. PubMed ID: 12821459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca.
    Fournier B; Gravel A; Hooper DC; Roy PH
    Antimicrob Agents Chemother; 1999 Apr; 43(4):850-5. PubMed ID: 10103190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter sequences necessary for high-level expression of the plasmid-associated ampC beta-lactamase gene blaMIR-1.
    Reisbig MD; Hanson ND
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4177-82. PubMed ID: 15504838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of a chromosomal class C beta-lactamase and its regulatory gene in Laribacter hongkongensis.
    Lau SK; Ho PL; Li MW; Tsoi HW; Yung RW; Woo PC; Yuen KY
    Antimicrob Agents Chemother; 2005 May; 49(5):1957-64. PubMed ID: 15855519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain.
    Castellanos LR; Donado-Godoy P; León M; Clavijo V; Arevalo A; Bernal JF; Timmerman AJ; Mevius DJ; Wagenaar JA; Hordijk J
    PLoS One; 2017; 12(1):e0170777. PubMed ID: 28125687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-locus sequence typing of Escherichia coli isolates with acquired ampC genes and ampC promoter mutations.
    Lewis JA; Moore PC; Arnold DL; Lawrance LM
    Diagn Microbiol Infect Dis; 2016 Nov; 86(3):265-267. PubMed ID: 27595455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.